Conversion Labs Stock Forecast, Price & News

-2.84 (-23.99 %)
(As of 04/14/2021 12:00 AM ET)
Today's Range
Now: $9.00
50-Day Range
MA: $16.39
52-Week Range
Now: $9.00
Volume7.12 million shs
Average Volume80,256 shs
Market Capitalization$148.80 million
P/E RatioN/A
Dividend YieldN/A
Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.

Industry, Sector and Symbol

Industry Miscellaneous manufacturing industries
Phone(866) 351-5907
Year FoundedN/A



Sales & Book Value

Annual Sales$12.47 million
Book Value($0.11) per share


Net Income$-3,140,000.00


Market Cap$148.80 million
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.17 out of 5 stars

Retail/Wholesale Sector

349th out of 383 stocks

Miscellaneous Manufacturing Industries Industry

21st out of 23 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
-2.84 (-23.99 %)
(As of 04/14/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CVLBD News and Ratings via Email

Sign-up to receive the latest news and ratings for CVLBD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Conversion Labs (OTCMKTS:CVLBD) Frequently Asked Questions

What stocks does MarketBeat like better than Conversion Labs?

Wall Street analysts have given Conversion Labs a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Conversion Labs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Conversion Labs' key executives?

Conversion Labs' management team includes the following people:
  • Justin Schreiber, Chairman, President & Chief Executive Officer
  • Stefan Galluppi, Chief Operating & Technology Officer, Director
  • Juan Manuel Piñeiro Dagnery, Chief Financial Officer & Controller
  • Joseph V. DiTrolio, Director & Chief Medical Officer-US
  • Eric H. Yecies, Chief Compliance Officer & General Counsel

Who are some of Conversion Labs' key competitors?

What is Conversion Labs' stock symbol?

Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLBD."

How do I buy shares of Conversion Labs?

Shares of CVLBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Conversion Labs' stock price today?

One share of CVLBD stock can currently be purchased for approximately $9.00.

How much money does Conversion Labs make?

Conversion Labs has a market capitalization of $148.80 million and generates $12.47 million in revenue each year.

How many employees does Conversion Labs have?

Conversion Labs employs 26 workers across the globe.

What is Conversion Labs' official website?

The official website for Conversion Labs is www.conversionlabs.com.

Where are Conversion Labs' headquarters?

Conversion Labs is headquartered at 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at (866) 351-5907 or via email at [email protected]

This page was last updated on 4/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.